Volume 2, Issue 1 (Winter 2017)                   J Res Urol 2017, 2(1): 29-32 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abbasi M. Prostate Cancer: A Case Report. J Res Urol. 2017; 2 (1) :29-32
URL: http://urology.umsha.ac.ir/article-1-43-en.html
Abstract:   (1284 Views)

Background and Objective: Prostate cancer is reported to affect approximately 70% of men and is the second leading cause of death in men. An early diagnosis and screening can reduce the associated complications and mortality rate.
Case Presentation: A 52-year-old man complaining of a backache for eight months reported to the hospital. The initial examination showed him to be suffering from an infiltrative bone tumor. The patient was initially diagnosed with multiple myeloma and was provided chemotherapy. Owing to a lack of response of the patient to the treatment, he was referred to an oncologist. Further evaluations showed him to be suffering from metastatic prostate cancer, and appropriate treatment was initiated.
Conclusion: Despite the advances in diagnostic tools and increasing accuracy of tests, clinical examination is important and considered a key component of the diagnosis of prostate cancer.

Keywords: prostate, cancer
Full-Text [PDF 675 kb]   (1225 Downloads)    
Type of Study: Applicable | Subject: Laparoscopy
Received: 2017/03/4 | Accepted: 2017/11/4 | Published: 2018/01/17

1. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison’s principles of internal medicine, 19th ed. USA2015. 2015. p 579-583. 2015
2. Society AC. Cancer Facts & Figures 2016: American Cancer Society; 2016 [Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2016/cancer-facts-and-figures-2016.pdf.
3. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70-98. [DOI] [PubMed]
4. Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304(21):2373-80. PMC3055173. [DOI]
5. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009;41(10):1058-60. [DOI] [PubMed]
6. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012;366(2):141-9. [DOI]
7. Tourinho-Barbosa RR, Pompeo AC, Glina S. Prostate cancer in Brazil and Latin America: epidemiology and screening. Int Braz J Urol. 2016;42(6):1081-90. [DOI] [PubMed]
8. Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM, Kastrinos F, et al. Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol. 2013;31(14):1713-8. [DOI] [PubMed]

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Journal of Research in Urology

Designed & Developed by : Yektaweb